{"name":"Olix Pharmaceuticals, Inc.","slug":"olix-pharmaceuticals-inc","ticker":"","exchange":"","domain":"olix.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxONElkSUNBV2Q0b21lX0JTV3ZDdWI3RC15X3FtVVRZM0VQcEZjZndwVXJNQXctRGx5b2hGV2FkN1VMTE1OUGJUS2c1bnBGTkRvUEkyRy1UOXFwV19GUTlPZ051dHRKYnpteGRrMWhTR29CUGN2bEdzRThXMjJUbVpLaEVzTlk?oc=5","date":"2026-02-02","type":"deal","source":"Yahoo Finance UK","summary":"Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - Yahoo Finance UK","headline":"Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE51SC1oaVVqMVg5bVhNNkJEOHVfa014RG1GbFFFZTBEUlMxZ2RnMzZGRTVFcDNZNUZRcWlOYXdMcVVfWHhDYk0zVmYxVVhBTzZzOGNYcE9CaExiYUNPZGpyOEdrelNnUk5JcXl2UzdR0gFyQVVfeXFMTUwxMUs0YW9UWS1ZQXdFemVkQVhRSDMxb3ZYb0RJWHJVdWo2SFBQZnp5RHZiMjBOTnpZcmRGOWtERE5EXzdBSjlDRGVHR2R6MjlySXRXMzV2VzZuZlJlUVhpd2ZDS2RNWnFzaEw2MEdHM2lR?oc=5","date":"2025-08-20","type":"pipeline","source":"koreabiomed.com","summary":"OliX secures ₩115 billion investment through convertible preferred shares - koreabiomed.com","headline":"OliX secures ₩115 billion investment through convertible preferred shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPajFfbGdqdWlqVFFYUjB5WUxxb2xweF9iMmg2bW1sbTJNSWtkRkJTbkV5aHNKWFFvMTJkdGtYZ01rZ3pmQ3AyeFJlZG1wZENVZl9TRUoxTEY1MTNsZTExcU5oQ09VOUR0YXRQeXZ6dGd6aEhoUW1Lck5WOFMza3IwdlBlQlM2VXhWSVNEYXp2TjBwN1dxYlVWZWp3ZTlKT0JIYUhTakVJUTNVUQ?oc=5","date":"2025-02-18","type":"deal","source":"BioWorld News","summary":"APAC deals abound: Lilly taps Advancell, Olix; Genome draws Ellipses - BioWorld News","headline":"APAC deals abound: Lilly taps Advancell, Olix; Genome draws Ellipses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNYnFpZW5zRDRLeE9MMHpIV3dKdHphS1RKdmp4cnJPTzhCSktDRDRpbE1jOTd2MnloRF9tcF9wY2g0QmtlM0k0X3NnT3B3R3JLYjdDd0hXVFljV2txWUw1ajE1TURHMHd3NVU1YXBpWjY0TDlMQ21BdzRQNzBGNmtYZ1VGSFQ3OUlHdWNXRGFtWUJXaWVsNklQRV9WUEdWcmd2Um41T3NTWHU1d0pPVkMxTkhCQW1uVmREV2NFS1lB?oc=5","date":"2025-02-12","type":"pipeline","source":"Contract Pharma","summary":"OliX, Lilly Enter Global Licensing Agreement for Cardiometabolic Indications - Contract Pharma","headline":"OliX, Lilly Enter Global Licensing Agreement for Cardiometabolic Indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPTE5tcm1vZmI4VU9FaldBU1ZzLXhWYVNYRzdOOVhXUmNuT3RQSENNMUcxYjNNZjNGckYyVWFmeWlsVm1XTi1hYmpyNjR1UnpYZ0tSTF9heHR6UmhDdnUyajVDVFN4MnMwQl9EblNVM2FwTTlYYmg5Vk14SEloc2ZzdWNqMFZPZGdBOXhkWGhNREY1X3RyOU5WVGlSbURYOUxtM0JkY0VzQk1ydG0wMkR6c2gwYmJ6U1ZjVmswR05McEZibXdZc0xUTFZFbUJJcHlJR1c5S0lZTFNGMTFLUjJDSk51dG5SUQ?oc=5","date":"2025-02-10","type":"pipeline","source":"Business Wire","summary":"OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications - Business Wire","headline":"OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPVVhqRlVXV0REbGNRbEdmOGI4UmhMYjNGVVdfU0xSLTRYQ2tPaVFfcFAyX2RlMnk0TGo0SmFtbWVxU0kzTmkxa2JGeXlsbkN5VURUVEtYdWI5RndRMURuNHlaRG83OHg4OGFUcFd0eWdQLUw1bmRMeHdWQjRSdEFKSmpfTXlTR29BajFnbjVDTFh4MW5PcnlPa0tzN2xwMWpkbzN6TlNCQmI2SGdGSWZTVXdjS3Q?oc=5","date":"2025-02-10","type":"deal","source":"Fierce Biotech","summary":"Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH - Fierce Biotech","headline":"Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1SaUEzaWV0cGV1T1dGZ0Y3aTZISDNUWHRfX1BtVlh3NFdCekdMR05pazh3Q1hkRHh1LUpXdTNsdmdVb1hHWjl1aTZjS1BueUp2dXczazhDWWtaRVlZSEZxemg4QnNjT0Q1MTNrc0dR0gFyQVVfeXFMUHpzdWsxSGdHck9qcXpHZE55N2swT2dKNzkyOVNkdm56WXdaUkNpMUszN1FrS1ZVZ2xnWVhNOVN2bDZZWE5iZHAwSGZnNHhLRHFzM19DcWdVRGFTYm91SmZGVEJJeFNDTjZ5cXNLNDVSVFh3?oc=5","date":"2025-02-10","type":"deal","source":"koreabiomed.com","summary":"OliX strikes $630 million deal with Lilly for obesity and liver disease drug - koreabiomed.com","headline":"OliX strikes $630 million deal with Lilly for obesity and liver disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPbXRpRm85MGlBYzZrekFDRFdQQ3Q4TC1jZ3A4aGlNWnhMNXg3NUJOSFVwWVNxZnlJYmpYQkQtTDE2Qy04X05VWnFqVWE1c0dVelpxRS1RUUxqQ0FsbTBlZm9RVDBuWmJOWXhHajNmckp0ZWw1dVFoanB2Tnc3MllYX21HUG85SmJTQlVEMzBXeWZEMVgwSUpDRXpnY1ozajQ?oc=5","date":"2025-02-10","type":"trial","source":"BioWorld News","summary":"Olix wins $630M deal from Eli Lilly for phase I MASH asset - BioWorld News","headline":"Olix wins $630M deal from Eli Lilly for phase I MASH asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBkV3V4ZXZuRlVVbnBzM3U0b0xpcDJqcUN2NWFRZktFdHpIc1pBc0NLa2tpZHFTaGVhV3h3N1p2UFp2czluLUtYY1drMlpnSjRkTG82MGJ3MjNsaUV4djNGYkR4aw?oc=5","date":"2024-06-21","type":"pipeline","source":"sg.finance.yahoo.com","summary":"OliX Pharmaceuticals, Inc (226950.KQ) company profile and facts - sg.finance.yahoo.com","headline":"OliX Pharmaceuticals, Inc (226950.KQ) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNS0w2a0F2RnFrMUNuRkVtVEluU3RzSzNNUGdLR3ZMSjRqMzFxSDR2UDM3VWJhNGRiN29ET05VbmlGYU10Si1MMGxwaTN5bFVfeVk1ZXhOejdGUUVIREw0YkU3TFVWaTNfRDdiYzdyTlpiSlFWVXVqVWJ6RVU0eHB0bWFSS0JiRV9nWF9xRW5ZV014dlRZclQyUVJlQUEzLUQ3Q1ZjSlBZaS1iRXhNZEpaazlRY055ZzlwdW5TVEg2aml6TUlxVDNHY2FXeXlSM1h6N1dzMkxJeFI0ZlVDOHZlLVZmWWlQaVY3X09Sa05ReUJNQQ?oc=5","date":"2023-12-22","type":"regulatory","source":"Business Wire","summary":"OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug - Business Wire","headline":"OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOeGRpazUzNkREZkVmT3M0aTRKcXE4NG1ZYWhsLU9PenBOVnQ3VkFkWGVISk44SnVLM1pXWnFKcU9qMDB3eE5nMW9EMUdPTlVQdHdYZ1BEUU9iZ3NGNjhIZWotR0labHNYX0lKSjFEWUJfaDByY0ZEaHJxTzVvNWVoaEcyYU8?oc=5","date":"2022-04-25","type":"pipeline","source":"Pharma Voice","summary":"How OliX Pharmaceuticals is riding the RNAi wave - Pharma Voice","headline":"How OliX Pharmaceuticals is riding the RNAi wave","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQOGZJV0xySmNRWmo3M255cGdnNFBLaHZ6dGlCRmU4OEJsc2Z4aFJtazRmNkZzTEN1VXFZdXZMZUdSTG5iT25FT3QwT1FXeHpSbFhUeFVyRG45LXBPME05NGNiN0lmMzU5QkkzaXNBWXBGNWdPVjhRSlZRNzhabkM5ZjVadUEtV0o3RVMzdzhGNEhOaDd0bDZmd2Q0eHpjUEp5YV9OSDdlTVdGaDlLN1FwTjZNVlhsbnZoVzdpSFZucjVhQlktMm9tRzhhSll2ZXhlRS10MVQ1TjJyYzFKWmQ1YWhSajRCRFZtSVFYVXFvU3Z0LTZNVWw1eHBKWGNsYlNEN1RaMEtfQXRmOE1XdC16T082YksyRUI2TzljbEJBSGFYLW5zWWtQYkplZHhoTW1wa1FBY0VPWlgwdEhNWUNwUmpZcU9Td0k?oc=5","date":"2021-10-12","type":"pipeline","source":"GlobeNewswire","summary":"Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing - GlobeNewswire","headline":"Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}